These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3455064)

  • 1. Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels.
    Hercz G; Andress DL; Norris KC; Shinaberger JH; Slatopolsky EA; Sherrard DJ; Coburn JW
    Trans Assoc Am Physicians; 1987; 100():139-46. PubMed ID: 3455064
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in bone histology after treatment with desferrioxamine.
    Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ
    Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
    [No Abstract]   [Full Text] [Related]  

  • 3. Aluminum and renal bone disease in Australia.
    Dunstan CR; Evans RA
    Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
    [No Abstract]   [Full Text] [Related]  

  • 4. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE; Johnson CA
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with aluminum-associated bone disease in end-stage renal disease patients.
    Joglar FM; Rivera CG; Burgos R; Huffer WE
    Transplant Proc; 1991 Apr; 23(2):1823-4. PubMed ID: 2053166
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ; Cowie JF; Robson JS
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long term CaCO3 treatment of chronic hemodialysis patients--an attempt to prevent and treat aluminum osteopathy].
    Matsubara M; Totsune K; Saito T; Yoshinaga K; Unagami H; Sato H
    Nihon Jinzo Gakkai Shi; 1988 Nov; 30(11):1349-54. PubMed ID: 3236516
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteomalacia and bone disease arising from aluminum.
    Coburn JW; Norris KC; Nebeker HG
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.
    Hercz G; Andress DL; Nebeker HG; Shinaberger JH; Sherrard DJ; Coburn JW
    Am J Kidney Dis; 1988 Jan; 11(1):70-5. PubMed ID: 3337101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone disorders in children with chronic renal insufficiency exposed to high ingestion of aluminum].
    Gordillo-Paniagua G; Valencia-Mayoral P; Mercado L; Medina-Mercado M
    Bol Med Hosp Infant Mex; 1990 May; 47(5):336-41. PubMed ID: 2390188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
    Faugere MC; Arnala IO; Ritz E; Malluche HH
    J Lab Clin Med; 1986 Jun; 107(6):481-7. PubMed ID: 3486929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aluminum on bone and cell localization.
    Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S
    Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
    [No Abstract]   [Full Text] [Related]  

  • 13. Paradoxical toxic and trophic osseous actions of aluminum: potential explanations.
    Quarles LD
    Miner Electrolyte Metab; 1991; 17(4):233-9. PubMed ID: 1813785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aluminum-related bone disease in chronic hemodialysis patients].
    Jara A; Rosenberg H; Bruhn C; Vaccarezza A; Vial S; Jalil R; Cisternas H
    Rev Med Chil; 1993 Jul; 121(7):769-76. PubMed ID: 8296081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic hypercalcaemia of chronic dialysis.
    Feest TG; Newrick P; Read DJ
    Proc Eur Dial Transplant Assoc; 1983; 19():248-52. PubMed ID: 6348738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum-induced dialysis osteodystrophy: the demise of "Newcastle bone disease"?
    Kerr DN; Ward MK; Arze RS; Ramos JM; Grekas D; Parkinson IS; Ellis HA; Owen JP; Simpson W; Dewar J
    Kidney Int Suppl; 1986 Feb; 18():S58-64. PubMed ID: 3457998
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralization.
    Costantini S; Bonucci E; Mocetti P; Ballanti P; Giordano R; Vernillo I; Ioppolo A; Mantovani A; Stasolla D
    Ann Ist Super Sanita; 1986; 22(2):689-95. PubMed ID: 3752831
    [No Abstract]   [Full Text] [Related]  

  • 20. Deferoxamine and aluminum removal.
    Swartz RD
    Am J Kidney Dis; 1985 Nov; 6(5):358-64. PubMed ID: 3904429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.